FNBT
PBYI icon

FineMark National Bank & Trust’s Puma Biotechnology PBYI Stock Holding History

FineMark National Bank & Trust’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-7
Closed -$1K – 1445
2015
Q3 		$1K Buy
7
+1
+17% +$95 ﹤0.01% 1419
2015
Q2 		$1K Hold
6
– – ﹤0.01% 1363
2015
Q1 		$1K Buy
6
+3
+100% +$641 ﹤0.01% 1345
2014
Q4 		$1K Hold
3
– – ﹤0.01% 1356
2014
Q3 		$1K Sell
3
-7
-70% -$1.44K ﹤0.01% 1331
2014
Q2 		$1K Hold
10
– – ﹤0.01% 1350
2014
Q1 		$1K Sell
10
-4
-29% -$470 ﹤0.01% 1365
2013
Q4 		$1K Buy
+14
New +$822 ﹤0.01% 1427

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FineMark National Bank & Trust's PBYI Position: Q4 2015 in Review

FineMark National Bank & Trust sold out of Puma Biotechnology (PBYI) in Q4 2015, closing a stake of 7 shares — an estimated $1K sold.

FineMark National Bank & Trust first reported a position in PBYI in Q4 2013 and held it in 8 quarters. The position peaked at $1K in Q3 2015. 133 funds tracked by Wall St. Rank hold PBYI as of Q4 2015.

  • FineMark National Bank & Trust reported no remaining Puma Biotechnology position as of Q4 2015 after selling out during the quarter.
  • FineMark National Bank & Trust sold 7 Puma Biotechnology shares in Q4 2015, an estimated $1K.
  • FineMark National Bank & Trust first reported a position in Puma Biotechnology in Q4 2013 and held it in 8 quarters.
  • FineMark National Bank & Trust's Puma Biotechnology position peaked at $1K in Q3 2015.
  • 133 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2015.

Based on FineMark National Bank & Trust's 13F filing for Q4 2015, filed 9 Feb 2016.